Evidence map›Paper›PMID 30670032›Full record

ArticleMalaria journal2019

Interaction between maternally derived antibodies and heterogeneity in exposure combined to determine time-to-first Plasmodium falciparum infection in Kenyan infants.

Arnold Reynaldi, Arlene E Dent, Timothy E Schlub, Sidney Ogolla, Rosemary Rochford, Miles P Davenport

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. The Prevalence of HumanTropical medicine and infectious disease · 2023
    Article
  7. Article
  8. Dynamics of IgG antibody response againstFrontiers in immunology · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Sociodemographic Factors Associated with Malaria Infection among Under-Five Children in Nigeria.Nigerian medical journal : journal of the Nigeria Medical Association
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 3 countries.

Arnold ReynaldiKirby Institute for Infection and Immunity, UNSW Australia, Sydney, NSW, 2052, Australia.
Arlene E DentCenter for Global Health and Diseases, Case Western Reserve University, Cleveland, OH, USA.
Timothy E SchlubFaculty of Medicine and Health, Sydney School of Public Health, The University of Sydney, Sydney, NSW, 2006, Australia.
Sidney OgollaCentre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
Rosemary RochfordDepartment of Immunology and Microbiology, University of Colorado, Denver, CO, USA.
Miles P DavenportKirby Institute for Infection and Immunity, UNSW Australia, Sydney, NSW, 2052, Australia. m.davenport@unsw.edu.au.ORCID http://orcid.org/0000-0002-4751-1831
Center for Global Health · USKenya Medical Research Institute · KEThe University of Sydney · AUUniversity of Colorado Denver · USUNSW Sydney · AU

Funding

Effects of Malaria on EBV Persistence in ChildrenR01CA102667 · NCI · UPSTATE MEDICAL UNIVERSITY · PI ROCHFORD, ROSEMARY · 2005 to 2014
$2.9M
Australian Research Council 180103873National Health and Medical Research Council 1082022National Health and Medical Research Council APP1080001National Institutes of Health R01 CA102667NCI NIH HHS R01 CA102667
6 · The paper itself

Abstract

backgroundStudies of the association between the level of anti-malarial antibody and protection from malaria infection can yield conflicting results if they fail to take into account differences in the malaria transmission rate. This can occur because high malaria exposure may drive high antibody responses, leading to an apparent positive association between immune response and infection rate. The neonatal period provides a unique window to study the protective effects of antibodies, because waning maternally-derived antibodies lead to different levels of protection with time.

methodsThis study uses data from two well-defined infant cohorts in Western Kenya with different burdens of malaria transmission. Survival models were used to assess how the magnitude of maternally derived malaria-specific IgG antibody (to 24 malaria antigens measured using Luminex beads) affected the time-to-first Plasmodium falciparum infection (detected by PCR). In addition, mathematical models were used to assess how the frequency of malaria infection varied between the cohorts with different exposure levels.

resultsDespite differences in underlying malaria incidence in the two regions, there was no difference in time-to-first malaria infection between the cohorts. However, there was a significant period of protection observed in children with high initial MSP1 (42 kDa fragment)-specific antibody levels, but this protection was not observed in children with low antibody levels. Children from the high transmission cohort had both longer initial periods of protection from malaria (attributable to higher initial antibody levels), but more rapid time-to-first-infection once malaria specific maternal antibodies declined below protective levels (attributable to higher exposure rates).

conclusionThis study demonstrates the complex interaction between passive (maternally-derived) immunity and the degree of malaria exposure in infants. Children from regions of high malaria transmission had higher levels of maternally-derived antibodies in early life, which led to a significant protection for several months. However, once this immunity waned, the underlying higher frequency of infection was revealed. A better understanding of the interaction between malaria exposure, immunity, and transmission risk will assist in identifying protective immune responses in P. falciparum infection.

Indexed as

Immunity, Maternally-AcquiredAntibodies, ProtozoanAntigens, ProtozoanChild, PreschoolCohort StudiesFemaleHumansImmunoglobulin GIncidenceInfantInfant, NewbornKenyaLongitudinal StudiesMalaria, FalciparumMalePlasmodium falciparumAntibodies, ProtozoanAntigens, ProtozoanImmunoglobulin GAntibodyHeterogeneity in exposureImmunityNewbornsPlasmodium falciparum malaria

Identifiers

PMID30670032
PMCPMC6343364
OpenAlexW2914825377

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.